Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA1

Emerg Infect Dis. 2019 Jul;25(7):1389-1393. doi: 10.3201/eid2507.181938.

Abstract

We analyzed antimicrobial susceptibility test results reported in healthcare-associated infections by California hospitals during 2014-2017. Approximately 3.2% of Enterobacteriaceae reported in healthcare-associated infections were resistant to carbapenems and 26.9% were resistant to cephalosporins. The proportion of cephalosporin-resistant Escherichia coli increased 7% (risk ratio 1.07, 95% CI 1.04-1.11) per year during 2014-2017.

Keywords: California; Enterobacteriaceae; United States; antimicrobial resistance; bacteria; carbapenems; cephalosporins; drug resistance; enteric infections; epidemiology; hospital; infections; multidrug-resistant.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • California / epidemiology
  • Carbapenems / pharmacology*
  • Cephalosporins / pharmacology*
  • Cross Infection*
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / genetics
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology*
  • Geography, Medical
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance*

Substances

  • Carbapenems
  • Cephalosporins